All In Biotech

Drug Trial Radar · NCT06819878

A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

A Phase III, Multicenter, Double-Blind, Placebo-Controlled, Treat-Through Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With RO7790121 in Patients With Moderately to Severely Active Crohn's Disease

Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 600 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

600

Planned (sponsor's estimate)

Start

Mar 17, 2025

Primary completion

Dec 31, 2028

Study completion Dec 31, 2033

Sponsor

Lead sponsor
Hoffmann-La RocheRoche (Genentech) (RHHBY)
Sponsor type
Industry
Collaborators
Chugai Pharmaceutical
First posted
Feb 11, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 16 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This Phase III, multicenter, double-blind, placebo-controlled treat-through study will evaluate the efficacy and safety of induction and maintenance therapy with Afimkibart (also known as RO7790121) in participants with moderately to severely active Crohn's disease (CD).

Conditions

  • Moderately to Severely Active Crohns Disease

Interventions

  • AfimkibartDrug

    Afimkibart will be administered as IV infusion. Afimkibart will be administered as SC injection.

  • PlaceboDrug

    Placebo matching IV afimkibart. Placebo matching SC afimkibart.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants with Clinical Remission per Crohn's Disease Activity Index (CDAI) ScoreTime frame: At Week 52
  2. Percentage of Participants with Endoscopic ResponseTime frame: At Week 52

Locations

375 sites in 38 countries. Site status is shown where the registry gives one.

  • Digestive Health Specialists of the Southeast (Gastroenterology Associates of Dothan) - Dothan

    Dothan, Alabama · Recruiting

  • Mayo Clinic Hospital

    Phoenix, Arizona · Recruiting

  • Arizona Digestive Health, P.C (ADH)

    Sun City, Arizona · Recruiting

  • University of Arizona-CATS Research Center

    Tucson, Arizona · Recruiting

  • Valley View Internal Medicine

    Garden Grove, California · Recruiting

  • 310 Clinical Research

    Inglewood, California · Recruiting

  • UCSD Medical Center

    La Jolla, California · Recruiting

  • University of California San Diego

    La Jolla, California · Recruiting

  • Gastro Care Associates

    Lancaster, California · Recruiting

  • Om Research LLC

    Lancaster, California · Recruiting

  • United Gastroenterologists

    Los Alamitos, California · Recruiting

  • Acclaim Clinical Research, Inc.

    San Diego, California · Withdrawn

  • Kaiser Permanente

    San Francisco, California · Recruiting

  • UCSF/Medical Center at Mount Zion

    San Francisco, California · Recruiting

  • Rocky Mountain Gastroenterology

    Littleton, Colorado · Recruiting

  • Peak Gastroenterology Surgery Center

    Lone Tree, Colorado · Recruiting

  • Access Research Institute

    Brooksville, Florida · Recruiting

  • Gastro Florida

    Clearwater, Florida · Recruiting

  • HealthMed Clinical Center Inc.

    Coral Gables, Florida · Recruiting

  • Hi Tech and Global Research, LLC

    Coral Gables, Florida · Recruiting

  • The Sister Life Research

    Hialeah, Florida · Recruiting

  • NeoClinical Research

    Hialeah, Florida · Recruiting

  • Clinical Research of Osceola, LLC

    Kissimmee, Florida · Recruiting

  • Florida Research Institute - Lakewood

    Lakewood Rch, Florida · Recruiting

  • LCC Medical Research Institute, LLC

    Miami, Florida · Recruiting

  • Ambert Medical Research

    Miami, Florida · Withdrawn

  • Orlando Regional Healthcare

    Orlando, Florida · Recruiting

  • Nodal Medical Center Research - NMC

    Tampa, Florida · Recruiting

  • University of South Florida School of Medicine Morsani Center for Advanced Health Care

    Tampa, Florida · Recruiting

  • Guardian Angel Research Center, LLC

    Tampa, Florida · Recruiting

  • Theia Clinical Research Centers, LLC

    Temple Terrace, Florida · Recruiting

  • Cleveland Clinic Florida

    Weston, Florida · Recruiting

  • Florida Medical Clinic - Orlando Health

    Zephyrhills, Florida · Recruiting

  • Digestive Healthcare of Georgia

    Atlanta, Georgia · Recruiting

  • Atlanta Gastroenterology Associates

    Atlanta, Georgia · Recruiting

  • Gastroenterology Associates of Central Georgia

    Macon, Georgia · Recruiting

  • Grand Teton Research Group, PLLC

    Idaho Falls, Idaho · Recruiting

  • Northwestern Memorial Hospital

    Chicago, Illinois · Recruiting

  • Illinois Gastroenterology Group-Glenview powered by GI Alliance

    Glenview, Illinois · Recruiting

  • GI Alliance - Gurnee

    Gurnee, Illinois · Recruiting

Showing 40 of 375 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.